Levetiracetam Modulates Brain Metabolic Networks and Transcriptomic Signatures in the 5XFAD Mouse Model of Alzheimer's disease.
Charles P. Burton, Evgeny J. Chumin, Alyssa Y. Collins, Scott A. Persohn, Kristen D. Onos, Ravi S. Pandey, Sara K. Quinney, Paul R. Territo
This study examines how levetiracetam affects brain metabolic networks and transcriptomic signatures in 5XFAD mice, showing dose- and sex-dependent changes in gene expression and cerebral metabolism.
Frontiers in Neuroscience · Jan 23, 2024Peer-reviewedNeuroscience